OMICS International https://www.omicsonline.org/ OMICS International is a scientific organization that drives the progress of research through open access journals and organizes international conferences, The best in science news, commentary, and research. https://www.omicsonline.org/ArchiveJADP/currentissue-alzheimers-disease-parkinsonism-open-access.php Journal of Alzheimers Disease & Parkinsonism Volume 7, Issue 4 https://www.omicsonline.org/open-access/investigating-basal-autophagic-activity-in-brain-regions-associated-withneurodegeneration-using-in-vivo-and-ex-vivo-models-2161-0460-1000337.php?aid=92429 Investigating Basal Autophagic Activity in Brain Regions Associated withNeurodegeneration using In Vivo and Ex Vivo Models Chrisna Swart, Akile Khoza, Khaalid Khan, Stephan Le Roux, Anton du Plessis and Ben Loos https://www.omicsonline.org/open-access/peptides-derived-from-neuronal-cell-cycle-like-kinase-5-activator-p35-inneurodegeneration-pathology-and-therapy-2161-0460-1000338.php?aid=92430 Peptides Derived from Neuronal Cell Cycle like Kinase 5 Activator p35 inNeurodegeneration Pathology and Therapy Philip Grant, Manju Bhaskar, Binukumar BK and Harish C Pant https://www.omicsonline.org/open-access/role-of-the-transcription-factor-nrf2-in-parkinsons-disease-newinsights-2161-0460-1000340.php?aid=92432 Role of the Transcription Factor Nrf2 in Parkinsons Disease NewInsights Isabel LastresBecker https://www.omicsonline.org/open-access/synaptic-function-and-dysfunction-in-alzheimers-disease-2161-0460-1000341.php?aid=92433 Synaptic Function and Dysfunction in Alzheimers Disease Origlia N and Domenici L https://www.omicsonline.org/open-access/the-prevention-of-alzheimers-disease-and-parkinsons-disease-bymonascus-purpureus-ntu-568fermented-compounds-2161-0460-1000342.php?aid=92434 The Prevention of Alzheimers Disease and Parkinsons Disease byMonascus purpureus NTU 568Fermented Compounds Chun Lin Lee and Tzu Ming Pan https://www.omicsonline.org/open-access/huntingtons-disease-unique-problems-or-similar-impact-to-otherdegenerative-neurological-disorders-2161-0460-1000343.php?aid=92670 Huntingtons Disease Unique Problems or Similar Impact to OtherDegenerative Neurological Disorders Steve Smith https://www.omicsonline.org/open-access/new-insight-into-alzheimers-disease-via-caspase-3cleaved-taupathogenic-role-in-tau-oligomer-formation-and-memory-deficits-2161-0460-1000344.php?aid=92671 New Insight into Alzheimers Disease via Caspase 3cleaved TauPathogenic Role in Tau Oligomer Formation and Memory Deficits Young Doo Kima, Jisu Parka and Yong Keun Jung https://www.omicsonline.org/open-access/urine-formaldehyde-a-noninvasive-marker-for-alzheimers-disease-2161-0460-1000345.php?aid=92673 Urine Formaldehyde A NonInvasive Marker for Alzheimers Disease Zhiqian Tong https://www.omicsonline.org/open-access/ethnic-differences-in-early-onset-alzheimers-disease-2161-0460-1000346.php?aid=92674 Ethnic Differences in Early Onset Alzheimers Disease HueiYang Chen and Peter K Panegyres https://www.omicsonline.org/open-access/united-nations-and-world-health-organisation-engagement-in-treatingglobal-mental-health-with-a-special-focus-on-dementia-2161-0460-1000347.php?aid=92675 United Nations and World Health Organisation Engagement in TreatingGlobal Mental Health with a Special Focus on Dementia Daniela Fisichella https://www.omicsonline.org/open-access/protein-gelation-around-axons-inhibits-action-potential-propagation-innerve-fibers-2161-0460-1000349.php?aid=92677 Protein Gelation around Axons Inhibits Action Potential Propagation inNerve Fibers Wade N Dauberman, Samuel Breit and Shaohua Xu https://www.omicsonline.org/open-access/ophthalmic-artery-flow-and-cognitive-performance-in-patients-withcarotid-artery-stenosis-2161-0460-1000350.php?aid=92678 Ophthalmic Artery Flow and Cognitive Performance in Patients withCarotid Artery Stenosis Kuo Lun Huang, Meng Yang Ho and TsongHai Lee https://www.omicsonline.org/open-access/exploring-the-genetic-architecture-of-parkinsons-disease-in-a-southernspanish-population-2161-0460-1000351.php?aid=92679 Exploring the Genetic Architecture of Parkinsons Disease in a SouthernSpanish Population Sara Bandreacutes Ciga, Clara Ruz, Francisco J Barrero, Francisco Escamilla Sevilla, Javier Pelegrina, Manuel Ramiacuterez, Francisco Vives1 and Raquel Duran https://www.omicsonline.org/open-access/citicoline-as-addon-treatment-in-alzheimers-disease-tips-from-theciticholinage-study-2161-0460-1000353.php?aid=92680 Citicoline as AddOn Treatment in Alzheimers Disease Tips from theCiticholinage Study Pietro Gareri, Alberto Castagna and The Citicholinage Study Group https://www.omicsonline.org/open-access/botulinum-toxin-type-a-and-physiokinesiterapy-in-the-treatment-of-pisasyndrome-2161-0460-1000354.php?aid=92681 Botulinum Toxin Type A and Physiokinesiterapy in the Treatment of PisaSyndrome Marvulli R, Mastromauro L, Falcicchio ML, Gallo GA, Napolitano M, Schivardi E, Fiore P, Megna M and Ianieri G https://www.omicsonline.org/open-access/exome-sequencing-of-extended-families-with-alzheimers-diseaseidentifies-novel-genes-implicated-in-cell-immunity-and-neuronal-funct-2161-0460-1000355.php?aid=92682 Exome Sequencing of Extended Families with Alzheimers DiseaseIdentifies Novel Genes Implicated in Cell Immunity and Neuronal Function Cukier HN, Kunkle BK, Hamilton KL, Rolati S, Kohli MA, Whitehead PL, Jaworski J, Vance JM, Cuccaro ML, Carney RM, Gilbert JR, Farrer LA, Martin ER, Beecham GW, Haines JL, and PericakVance MA https://www.omicsonline.org/open-access/efficacy-of-incobotulinumtoxin-type-a-xeomin-in-the-management-ofsialorrhea-in-neurodegenerative-diseases-2161-0460-1000356.php?aid=92683 Efficacy of Incobotulinumtoxin Type A Xeomin in the Management ofSialorrhea in Neurodegenerative Diseases Marvulli R, Mastromauro L, De Venuto G, Napolitano M, Falcicchio M, Gallo GA, Schivardi E, Fiore P, Megna M and Ianieri G https://www.omicsonline.org/open-access/comparative-analysis-of-nasal-therapy-with-soluble-and-liposomalforms-of-curcumin-on-rats-with-alzheimers-disease-model-2161-0460-1000357.php?aid=92693 Comparative Analysis of Nasal Therapy with Soluble and LiposomalForms of Curcumin on Rats with Alzheimers Disease Model Sokolik VV, Berchenko OG and Shulga SM https://www.omicsonline.org/open-access/identification-of-serum-antigadd34-antibody-as-a-common-marker-ofdiabetes-mellitus-and-parkinson-disease-2161-0460-1000358.php?aid=92785 Identification of Serum AntiGADD34 Antibody as a Common Marker ofDiabetes Mellitus and Parkinson Disease Kazuo Sugimoto, Go Tomiyoshi, Masahiro Mori, Satoshi Kuwabara, Shigeki Hirano, Setsu Sawai, Minako Beppu, Mayumi Muto, Akiyuki Uzawa, Kenichiro Kitamura, Minoru Takemoto, Akiko Hattori, Masashi Yamamoto, Kazuki Kobayashi, Harukiyo Kawamura, Ryoichi Ishibashi, Koutaro Yokote, Seiichiro Mine, Toshio Machida, Eiichi Kobayashi, Yoichi Yoshida, Tomoo Matsutani, Yasuo Iwadate, Yoshio Kobayashi, Rika Nakamura, Natsuko Shinmen, Hideyuki Kuroda, Hao Wang, XiaoMeng Zhang and Takaki Hiwa https://www.omicsonline.org/open-access/alzheimers-disease-pathogenesis-the-denied-access-model-2161-0460-1000359.php?aid=92694 Alzheimers Disease Pathogenesis The Denied Access Model Wade N Dauberman and Shaohua Xu https://www.omicsonline.org/open-access/effect-gpi-stimulation-on-human-thalamic-neuronal-activity-a-decadelater-2161-0460-1000360.php?aid=92695 Effect GPi Stimulation on Human Thalamic Neuronal Activity A DecadeLater Etienne Pralong https://www.omicsonline.org/open-access/the-mild-cognitive-impairment-mci-in-searching-for-its-clinical-identitycomment-of-the-nedices-cohort-data-2161-0460-1000361.php?aid=92696 The Mild Cognitive Impairment MCI in Searching for its Clinical IdentityComment of the NEDICES Cohort Data Feacutelix Bermejo P